Plerixafor generally refers to Plerixafor Injection, which can treat non-Hodgkin’s lymphoma and multiple myeloma. It is often combined with granulocyte colony-stimulating factor in the clinic to treat patients with non-Hodgkin’s lymphoma and multiple myeloma, and to mobilize hematopoietic stem cells into the peripheral blood in order to facilitate the completion of HSC collection and autologous transplantation. The dosage of Plerixafor Injection needs to be calculated according to the height of the patient in order to achieve the desired therapeutic effect. It is clinically found that some patients may experience adverse reactions such as diarrhea, nausea, fatigue, dizziness, and vomiting after applying Plerixafor Injection. If patients are allergic to Plerixafor Injection, it is prohibited to prevent inducing allergic reactions or aggravating the condition. Patients need to pay attention to the review of liver and kidney function, blood routine and so on during the use of the drug. For drivers and those who operate machines, this drug is used with caution. It is recommended to use Plerixafor Injection under the guidance of a physician, and not to use the drug or adjust the dosage on your own. If the drug is accompanied by uncomfortable symptoms, it is necessary to inform the doctor in time to deal with it.